4/24
11:45 pm
scni
Institutional Capital Returns as This Microcap Biotech Locks In Fresh Funding [Globe and Mail, The (Toronto, Canada)]
Low
Report
Institutional Capital Returns as This Microcap Biotech Locks In Fresh Funding [Globe and Mail, The (Toronto, Canada)]
4/24
08:00 am
scni
Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing
High
Report
Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing
4/23
06:02 am
scni
Scinai Immunotherapeutics (SCNI) had its "sell (e+)" rating reaffirmed by
Weiss Ratings .
Medium
Report
Scinai Immunotherapeutics (SCNI) had its "sell (e+)" rating reaffirmed by
Weiss Ratings .
4/6
07:00 am
scni
Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities
Medium
Report
Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities
4/1
07:48 am
scni
Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration [TheStreet.com]
High
Report
Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration [TheStreet.com]
4/1
07:35 am
scni
Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration
High
Report
Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration
3/19
07:50 am
scni
Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026
Medium
Report
Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026
3/16
04:14 pm
scni
Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price [Yahoo! Finance]
Medium
Report
Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price [Yahoo! Finance]
4/27
04:01 pm
scni
Form 6-K Scinai Immunotherapeutic For: Apr 27
Low
Report
Form 6-K Scinai Immunotherapeutic For: Apr 27
4/1
07:36 am
scni
Form 20-F Scinai Immunotherapeutic For: Dec 31
High
Report
Form 20-F Scinai Immunotherapeutic For: Dec 31
3/26
08:41 am
scni
Form 3 Scinai Immunotherapeutic For: Mar 18 Filed by: Mark Elad
Medium
Report
Form 3 Scinai Immunotherapeutic For: Mar 18 Filed by: Mark Elad
3/23
09:17 am
scni
Form 6-K Scinai Immunotherapeutic For: Mar 23
Medium
Report
Form 6-K Scinai Immunotherapeutic For: Mar 23
3/19
10:08 am
scni
Form 6-K Scinai Immunotherapeutic For: Mar 19
Low
Report
Form 6-K Scinai Immunotherapeutic For: Mar 19
3/18
10:08 am
scni
Form 3 Scinai Immunotherapeutic For: Mar 18 Filed by: MARGOLIN YAEL
Low
Report
Form 3 Scinai Immunotherapeutic For: Mar 18 Filed by: MARGOLIN YAEL
3/18
10:06 am
scni
Form 3 Scinai Immunotherapeutic For: Mar 18 Filed by: Ben-Or Uri
Low
Report
Form 3 Scinai Immunotherapeutic For: Mar 18 Filed by: Ben-Or Uri
3/18
10:05 am
scni
Form 3 Scinai Immunotherapeutic For: Mar 18 Filed by: Moed Samuel J
Low
Report
Form 3 Scinai Immunotherapeutic For: Mar 18 Filed by: Moed Samuel J
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register